User Comments Most Liked Latest
Login to join the conversation.
Reddit Mentions Today Week Month
$GUTS did I call it?
$GUTS Breaking imminent
$GUTS watch out $2.15 coming then it's moon
$GUTS: How to make money on other people losing weight? Summary GUTS has an opportunity to address the obesity market in a way that GLP-1s cannot, and I have an unusual degree of confidence that the tech works. 10 million Americans are on a GLP-1 and that number is increasing. …
$GUTS is putting on a technical masterclass. This isn't random volatility; this is systematic, algorithmic buying. The chart is printing a textbook "Stair-Step" Accumulation pattern, and we just launched into the next Markup Phase.
$GUTS is putting on a technical masterclass. This isn't random volatility; this is systematic, algorithmic buying. The chart is printing a textbook "Stair-Step" Accumulation pattern, and we just launched into the next Markup Phase.
Can we make money while people lose weight? Inverse McDonald's bet. I think so. Unpopular opinion: $GUTS solves this problem $GUTS is putting on a technical masterclass. This isn't random volatility; this is systematic, algorithmic buying. The chart is printing a textbook "Stair-Step" Accumulation pattern, and we just launched into …
$GUTS is solving this problem
$GUTS is solving this problem
$GUTS solves this problem
🤫 $GUTS
$GUTS ownership breakdown. Massive hedge funds and institutions ownership!
$GUTS is putting on a technical masterclass. This isn't random volatility; this is systematic, algorithmic buying. The chart is printing a textbook "Stair-Step" Accumulation pattern, and we just launched into the next Markup Phase.
An update to Fractyl Health ($GUTS), a great biotech stock with several short-term catalysts. I posted recently about Fractyl Health ($GUTS) and why I think it is the most promising biotech right now. You can read more [here](https://www.reddit.com/r/pennystocks/comments/1p0803b/why_i_feel_that_fractyl_health_guts_is_the_most/). Since then, they were successful in their first of several short-term catalysts …
$GUTS HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Fractyl Health, Inc. (GUTS) MASSIVE NEW GLP-1 DATA: Patients who stopped their #GLP1 after losing 24% of their body weight held those results for 6 months after a SINGLE #Revita procedure. Only 1.5% weight change.
It takes guts to invest in $GUTS https://finance.yahoo.com/news/fractyl-health-reports-positive-6-120000448.html Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with Revita (n=17); published third-party studies after GLP-1 withdrawal alone have shown ~10% …
$GUTS haven't you been warned?
$GUTS BIG news today! More catalysts to come
$GUTS 🚀 breaking out on incredible news
Looking only at price/news history, GUTS is set up for a rug pull
$GUTS is the next 10x 🚀
GUTS catalysts coming 🚀 fractyl health
GUTS catalysts coming 🚀 fractyl health Canaccord raised the firm's price target on Fractyl Health to $8 from $6 and keeps a Buy rating on the shares. The firm said the company's 3Q25 report was incremental following REMAIN-1 data in Sept which surprised to the upside. After digesting the data …
$GUTS Canaccord raised the firm's price target on Fractyl Health to $8 from $6 and keeps a Buy rating on the shares. The firm said the company's 3Q25 report was incremental following REMAIN-1 data in Sept which surprised to the upside. After digesting the data the firm increaed its POS …
What this chart tells me is that $GUTS has rejected any movement above 200dma. Shorts it is.
GUTS > 200dma
$GUTS has 144 institutional owners and shareholders that have filed 13D/G or 13F forms Fractyl Health, Inc. (US:GUTS) has 144 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,869,462 shares. Largest shareholders include Nantahala Capital …
$GUTS has 144 institutional owners and shareholders that have filed 13D/G or 13F forms Fractyl Health, Inc. (US:GUTS) has 144 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,869,462 shares. Largest shareholders include Nantahala Capital …
I was holding 2000 shares and continuing holding on Friday thinking today would bring a bump. Well I was wrong, so I sold today at 1.22 and made $40! That stupid I could have sold on Friday and made $650! At least not a L, now it’s on to the …
$GUTS has 144 institutional owners and shareholders that have filed 13D/G or 13F forms! Fractyl Health, Inc. (US:GUTS) has 144 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,869,462 shares. Largest shareholders include Nantahala Capital …
$GUTS > 200dma
$GUTS > 200dma
It takes guts to invest in $GUTS
GUTS a Peter Thiel play. 74% owned by Big Money!
It takes guts to invest in $GUTS $GUTS 🚨🚀 Canaccord raised the firm's price target on Fractyl Health to $8 from $6
It takes guts to invest in $GUTS
It takes guts to invest in $GUTS
$GUTS Canaccord raised the firm's price target on Fractyl Health to $8 from $6 Canaccord raised the firm's price target on Fractyl Health to $8 from $6 and keeps a Buy rating on the shares. The firm said the company's 3Q25 report was incremental following REMAIN-1 data in Sept which …
GUTS a Peter Thiel play
GUTS a Peter Thiel play GUTS — The Tiny Biotech Aiming at the Biggest Market in Medicine Most biotechs chase niche diseases. Fractyl Health (GUTS) is doing the exact opposite: they’re going after metabolic disease, one of the biggest and fastest-growing markets in the world
GUTS a Peter Thiel play Peter Thiel is betting on GUTS. GUTS is one of the few small biotechs going after the GLP-1 market without trying to copy Novo/Lilly. Instead of weekly injections, they’re developing durable gene therapies that could provide long-lasting GLP-1 activity from inside the body after a …
Why I feel that Fractyl Health (GUTS) is the most promising penny-biotech right now Potential 10x
https://preview.redd.it/4fc4b05rd12g1.png?width=699&format=png&auto=webp&s=07d2384d650cf2b0ec32ed03a0371e7baae71547 Patent received for $GUTS
Why I feel that Fractyl Health (GUTS) is the most promising penny-biotech right now For those of us that have been investing/trading biotechs, we know how rare is to find a company with all the right ingredients for massive growth, such as huge total addressable market, many short-term catalysts in …
Related News
No related news found for this ticker.
Badges / Notes
- No notable badges.
Total Off-Exchange Volume: 2.3 million
Values over 50% Short often indicate hidden bearish pressure from institutions.
🏆 Master Buzz Score: 3/15
Capitol Trades
| Date | Politician | Amount |
|---|---|---|
| No recent trades found. | ||
Insider Trades
| Date | Insider | Value |
|---|---|---|
| No recent trades found. | ||
Institutional Holdings (Whales)
| Institution | Shares | Value | % Held | Date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 12,136,917 | $19.1 million | 0.0886% | Sep 30, 2025 |
| SilverArc Capital Management, LLC | 10,600,000 | $16.6 million | 0.0773% | Sep 30, 2025 |
| Alyeska Investment Group, L.p. | 5,648,371 | $8.9 million | 0.0412% | Sep 30, 2025 |
| Woodline Partners LP | 5,506,534 | $8.6 million | 0.0402% | Sep 30, 2025 |
| Catalio Capital Management, LP | 5,214,236 | $8.2 million | 0.0380% | Sep 30, 2025 |
| Rosalind Advisors, Inc. | 5,000,000 | $7.9 million | 0.0365% | Sep 30, 2025 |
| General Catalyst Group Management, LLC | 4,884,193 | $7.7 million | 0.0356% | Sep 30, 2025 |
| Deer Management Co. LLC | 4,770,901 | $7.5 million | 0.0348% | Sep 30, 2025 |
| Hcc Manager LLC | 4,673,871 | $7.3 million | 0.0341% | Sep 30, 2025 |
| 683 Capital Management LLC | 4,650,000 | $7.3 million | 0.0339% | Sep 30, 2025 |
No comments yet. Be the first!